![](/img/cover-not-exists.png)
MP87-11 INTERIM ANALYSIS OF AN OPEN LABEL PHASE II STUDY OF ENZALUTAMIDE AND RADIUM RA 233 DICHLORIDE IN SYMPTOMATIC, METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS.
Shore, Neal, Schellhammer, Paul, Tutrone, Ronald, Mariados, Neil, Harrelson, StaceyVolume:
199
Language:
english
Journal:
The Journal of Urology
DOI:
10.1016/j.juro.2018.02.2911
Date:
April, 2018
File:
PDF, 770 KB
english, 2018